Angle PLC
LSE:AGL

Watchlist Manager
Angle PLC Logo
Angle PLC
LSE:AGL
Watchlist
Price: 7.75 GBX Market Closed
Market Cap: 25m GBX

Wall Street
Price Targets

AGL Price Targets Summary
Angle PLC

Wall Street analysts forecast AGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGL is 40.8 GBX with a low forecast of 40.4 GBX and a high forecast of 42 GBX.

Lowest
Price Target
40.4 GBX
421% Upside
Average
Price Target
40.8 GBX
426% Upside
Highest
Price Target
42 GBX
442% Upside
Angle PLC Competitors:
Price Targets
EMBLA
Embla Medical hf
48% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
3% Downside
SUS
Surgical Science Sweden AB
64% Upside
GMED
Globus Medical Inc
38% Upside
IRMD
IRadimed Corp
38% Upside
PODD
Insulet Corp
27% Upside
SIBN
SI-BONE Inc
88% Upside
EKF
EKF Diagnostics Holdings PLC
60% Upside

Revenue
Forecast

Revenue Estimate
Angle PLC

For the last 3 years the compound annual growth rate for Angle PLC's revenue is 42%. The projected CAGR for the next 4 years is 134%.

42%
Past Growth
134%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Angle PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Angle PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGL's stock price target?
Price Target
40.8 GBX

According to Wall Street analysts, the average 1-year price target for AGL is 40.8 GBX with a low forecast of 40.4 GBX and a high forecast of 42 GBX.

What is Angle PLC's Revenue forecast?
Projected CAGR
134%

For the last 3 years the compound annual growth rate for Angle PLC's revenue is 42%. The projected CAGR for the next 4 years is 134%.

Back to Top